Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LLME Treated DLI for Immune Reconstitution After Stem Cell Transplant
NCT00429039Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Sep 2000
- Primary completion
- Oct 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of l-leucyl-l-leucine methyl ester in allogeneic hematopoietic stem cell transplantation, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Sep 2000; status: terminated.
02
Drugs
l-leucyl-l-leucine methyl ester
03
Conditions
allogeneic hematopoietic stem cell transplantation
Beyond the preview
Go deeper on NCT00429039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429039.